Protocol·One
Editorial reference, not medical advice. BPC-157 is not a normal FDA-approved consumer drug. This report checks source evidence before any dose math. It does not approve a product or tell you to use it.

Free tool · BPC-157 source check

Check the source before the syringe.

For the dad evaluating a BPC-157 "prescription," clinic vial, oral capsule, or research vendor. The output is a source-confidence score, hard-stop list, questions to ask, and whether the calculator should wait.

Run the check

Score the source.

Price does not prove trust. It only helps reveal hidden pharmacy, consult, refill, and follow-up terms.

Evidence you can see
Red flags

Your report

The calculator is not step one.

Run the check and we will score the source, show hard stops, list the missing evidence, and only route to dose math when the source clears the minimum bar.

Why this exists

BPC needs a trust gate before dose math.

Prescription claim

If someone says prescription, they should be able to name the clinician, pharmacy, product, route, strength, label, and follow-up plan.

Research vendor

A COA can support identity and purity, but it does not turn a research vendor into a human-use pharmacy.

Injectable

For injectable products, sterility and endotoxin evidence are not optional details. They are the line before syringe math.

Reference anchors: FDA compounding risk page, FDA July 23-24, 2026 PCAC meeting, and OPSS BPC-157 warning.